Impact of relative dose intensity of standard regimens on survival in elderly patients aged 80 years and older with diffuse large B-cell lymphoma.
作者:
主题词
老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);环磷酰胺(Cyclophosphamide);多柔比星(Doxorubicin);人类(Humans);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);泼尼松(Prednisone);参考标准(Reference Standards);治疗结果(Treatment Outcome);长春新碱(Vincristine)
DOI
10.3324/haematol.2019.234435
PMID
31919079
发布时间
2022-05-31
- 浏览2

Haematologica
e415-e418页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文